NCT06742554

Comparative Efficacy of Buprenorphine Transdermal Patch Versus Tramadol in Postoperative Analgesia for Shoulder Arthroscopy

Comparative Efficacy of Buprenorphine Transdermal Patch Versus Tramadol in Postoperative Analgesia for Shoulder Arthroscopy: a Randomized Controlled Trial.

• Status: Active Not Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: medina medical center · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study compares the efficacy, safety, and patient satisfaction of the Buprenorphine 10 mg transdermal patch versus Tramadol for postoperative analgesia in shoulder arthroscopic surgery. The study hypothesizes that Buprenorphine provides superior pain relief with fewer side effects compared to Tramadol.

Conditions

• Postoperative Pain
• Shoulder Pain
• Opioid Analgesia
• Tramadol
• Buprenorphine
• Arthroscopy
• Interscalene Brachial Plexus Block
• Analgesic

Interventions

Type	Name	Description
DRUG	Buprenorphine transdermal patch	Buprenorphine Transdermal Patch (10 mg): Applied once before surgery for continuous pain control. Interscalene Brachial Plexus Block: Administered intraoperatively using 25 mL of 0.5% bupivacaine.
DRUG	Tramadol	Tramadol: Administered orally or intravenously at a standard dose of 100 mg every 8 hours, based on patient-reported pain levels. Interscalene Brachial Plexus Block: Administered intraoperatively using 25 mL of 0.5% bupivacaine.

Timeline

• Start date: 2024-12-01
• Primary completion: 2025-04-01
• Completion: 2025-04-30
• First posted: 2024-12-19
• Last updated: 2024-12-20

Locations

1 site across 1 country: Saudi Arabia

Regulatory

• FDA-regulated drug study